Nuvectis Pharma (NVCT)
(Delayed Data from NSDQ)
$6.00 USD
-0.17 (-2.76%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $5.98 -0.02 (-0.33%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Nuvectis Pharma, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NVCT 6.00 -0.17(-2.76%)
Will NVCT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVCT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVCT
Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?
Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
NVCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nuvectis Pharma (NVCT) Is a Great Choice for 'Trend' Investors, Here's Why
Wall Street Analysts Predict a 169.94% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know
Other News for NVCT
Nuvectis Pharma Inc Reports Q2 2025 EPS of -$0. ...
Nuvectis Pharma GAAP EPS of -$0.30
Nuvectis Pharma (NVCT) Strengthens Position with Promising Trial Results
Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights | ...
Nuvectis Pharma reports Q2 EPS (30c) vs. (26c) last year